An interventional study of Healing Touch and Standard care in Breast Cancer, sponsored by Stanford University. Completed at 1 site in United States. Open to female participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2022-06-23.
Sponsored by Stanford University · Not applicable, Interventional, and Treatment
To study if Healing Touch is effective during chemotherapy treatment for breast cancer
To study the effectiveness of Healing Touch provided during chemotherapy infusions on the experience of women undergoing treatment for breast cancer. Healing Touch (HT) is a gentle, non-invasive form of energy-balancing work that promotes relaxation and can help manage the side effects of chemotherapy.
12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.
This study's enrollment of 32 is below the median of 72 across 9,303 interventional studies indexed under Breast Neoplasms.
Browse Breast Neoplasms studies →Stanford University is the lead sponsor of 2,117 studies on the registry; 425 are open to participants now.
Of its 259 completed or terminated interventional studies of FDA-regulated products, 197 (76%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:- Stage I or II breast cancer
Exclusion Criteria:- Previous chemotherapy exposure
A a gentle, non-invasive form of energy-balancing work that promotes relaxation and can help manage the side effects of chemotherapy. It occurs every other week (during their infusion).
Procedure: Healing Touch · Other: Standard care
Guided relaxation every other week (during their infusion).
Other: Standard care · Procedure: guided relaxation
Standard care
Other: Standard care
every other week (during their infusion)
Adriamycin, cyclophosphamide, and paclitaxel administered as standard of care
FACT-B summary score
Time frame: Baseline, 6 wks, 14 wks
Domain scores for FACT-B; BSI-18; FACIT-Fatigue; nausea measured on a Likert scale
Time frame: Baseline, 6 wks, 14 wks
This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stanford University